BMO Capital Maintains Outperform on Corteva, Raises Price Target to $100

Benzinga Newsdesk www.benzinga.com Positive 89.9%

Neg 0% Neu 0% Pos 89.9%

BMO Capital analyst Joel Jackson maintains Corteva (NYSE:CTVA) with a Outperform and raises the price target from $95 to $100.